Scandinavian ChemoTech AB (publ)

OM:CMOTEC B Stok Raporu

Piyasa değeri: SEK 39.7m

Scandinavian ChemoTech Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Scandinavian ChemoTech is forecast to grow earnings and revenue by 32.2% and 58.2% per annum respectively.

Anahtar bilgiler

32.2%

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Medical Equipment kazanç büyümesi32.8%
Gelir büyüme oranı58.2%
Gelecekteki özkaynak getirisin/a
Analist kapsamı

Low

Son güncelleme13 Aug 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Kazanç ve Gelir Büyüme Tahminleri

OM:CMOTEC B - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (SEK Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/202622-7N/AN/A1
12/31/202513-11N/AN/A1
12/31/20247-14N/AN/A1
6/30/20245-17-14-13N/A
3/31/20244-19-19-18N/A
12/31/20233-21-19-18N/A
9/30/20233-22-20-20N/A
6/30/20232-23-21-21N/A
3/31/20230-23-20-19N/A
12/31/20220-23-20-19N/A
9/30/20220-22-23-20N/A
6/30/20220-22-25-22N/A
3/31/20222-20-22-18N/A
12/31/20213-18-22-19N/A
9/30/20213-15-15-13N/A
6/30/20213-12-11-9N/A
3/31/20212-11-12-10N/A
12/31/20201-12-10-8N/A
9/30/20202-14-16-12N/A
6/30/20202-14-16-12N/A
3/31/20204-13-16-12N/A
12/31/20195-12-16-11N/A
9/30/20195-10-10-6N/A
6/30/20196-9-13-8N/A
3/31/20195-9-10-6N/A
12/31/20185-8-9-5N/A
9/30/20184-6-12-9N/A
6/30/20184-6-8-5N/A
3/31/20183-7N/A-9N/A
12/31/20172-8N/A-10N/A
9/30/20172-10N/AN/AN/A
6/30/20172-8N/A-8N/A
3/31/20172-6N/AN/AN/A
12/31/20162-4N/AN/AN/A
9/30/20161-2N/AN/AN/A
6/30/20161-1N/A4N/A
6/30/2015N/A0N/AN/AN/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: CMOTEC B is forecast to remain unprofitable over the next 3 years.

Kazançlar ve Piyasa: CMOTEC B is forecast to remain unprofitable over the next 3 years.

Yüksek Büyüme Kazançları: CMOTEC B is forecast to remain unprofitable over the next 3 years.

Gelir ve Pazar: CMOTEC B's revenue (58.2% per year) is forecast to grow faster than the Swedish market (0.01% per year).

Yüksek Büyüme Geliri: CMOTEC B's revenue (58.2% per year) is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if CMOTEC B's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin